Literature DB >> 26921500

NF-YA splice variants have different roles on muscle differentiation.

Valentina Basile1, Fiorenza Baruffaldi2, Diletta Dolfini3, Silvia Belluti1, Paolo Benatti1, Laura Ricci1, Valentina Artusi4, Enrico Tagliafico4, Roberto Mantovani3, Susanna Molinari5, Carol Imbriano6.   

Abstract

The heterotrimeric CCAAT-binding factor NF-Y controls the expression of a multitude of genes involved in cell cycle progression. NF-YA is present in two alternatively spliced isoforms, NF-YAs and NF-YAl, differing in 28 aminoacids in the N-terminal Q-rich activation domain. NF-YAs has been identified as a regulator of stemness and proliferation in mouse embryonic cells (mESCs) and human hematopoietic stem cells (hHSCs), whereas the role of NF-YAl is not clear. In the muscle system, NF-YA expression is observed in proliferating cells, but barely detectable in terminally differentiated cells in vitro and adult skeletal muscle in vivo. Here, we show that NF-YA inactivation in mouse myoblasts impairs both proliferation and differentiation. The overexpression of the two NF-YA isoforms differentially affects myoblasts fate: NF-YAs enhance cell proliferation, while NF-YAl boosts differentiation. The molecular mechanisms were investigated by expression profilings, detailing the opposite programs of the two isoforms. Bioinformatic analysis of the regulated promoters failed to detect a significant presence of CCAAT boxes in the regulated genes. NF-YAl activates directly Mef2D, Six genes, and p57kip2 (Cdkn1c), and indirectly the myogenic regulatory factors (MRFs). Specifically, Cdkn1c activation is induced by NF-Y binding to its CCAAT promoter and by reducing the expression of the lncRNA Kcnq1ot1, a negative regulator of Cdkn1c transcription. Overall, our results indicate that NF-YA alternative splicing is an influential muscle cell determinant, through direct regulation of selected cell cycle blocking genes, and, directly and indirectly, of muscle-specific transcription factors.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alternative splicing; Gene expression; Muscle differentiation; NF-Y; Transcription factor

Mesh:

Substances:

Year:  2016        PMID: 26921500     DOI: 10.1016/j.bbagrm.2016.02.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  13 in total

Review 1.  NF-Y (CBF) regulation in specific cell types and mouse models.

Authors:  Sankar N Maity
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2016-11-02       Impact factor: 4.490

Review 2.  The animal nuclear factor Y: an enigmatic and important heterotrimeric transcription factor.

Authors:  Guilin Li; Hang Zhao; Lijun Wang; Ying Wang; Xingqi Guo; Baohua Xu
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

3.  Rev-Erb co-regulates muscle regeneration via tethered interaction with the NF-Y cistrome.

Authors:  Ryan D Welch; Chun Guo; Monideepa Sengupta; Katherine J Carpenter; Natalie A Stephens; Stacy A Arnett; Marvin J Meyers; Lauren M Sparks; Steven R Smith; Jinsong Zhang; Thomas P Burris; Colin A Flaveny
Journal:  Mol Metab       Date:  2017-05-19       Impact factor: 7.422

4.  LINC01016 promotes the malignant phenotype of endometrial cancer cells by regulating the miR-302a-3p/miR-3130-3p/NFYA/SATB1 axis.

Authors:  Xin Pan; Da Li; Jianing Huo; Fanfei Kong; Hui Yang; Xiaoxin Ma
Journal:  Cell Death Dis       Date:  2018-02-21       Impact factor: 8.469

Review 5.  Alternative Splicing of Transcription Factors Genes in Muscle Physiology and Pathology.

Authors:  Carol Imbriano; Susanna Molinari
Journal:  Genes (Basel)       Date:  2018-02-19       Impact factor: 4.096

6.  SSEA3 and Sialyl Lewis a Glycan Expression Is Controlled by B3GALT5 LTR through Lamin A-NFYA and SIRT1-STAT3 Signaling in Human ES Cells.

Authors:  Bi-He Cai; Hsueh-Yi Lee; Chi-Kan Chou; Po-Han Wu; Hsiang-Chi Huang; Chia-Chun Chao; Hsiao-Yu Chung; Reiji Kannagi
Journal:  Cells       Date:  2020-01-10       Impact factor: 6.600

7.  Discovery, characterization and potential roles of a novel NF-YAx splice variant in human neuroblastoma.

Authors:  Lucia Cappabianca; Antonietta Rosella Farina; Lucia Di Marcotullio; Paola Infante; Daniele De Simone; Michela Sebastiano; Andrew Reay Mackay
Journal:  J Exp Clin Cancer Res       Date:  2019-12-05

8.  Live cell dynamics of the NF-Y transcription factor.

Authors:  David G Priest; Andrea Bernardini; Jieqiong Lou; Roberto Mantovani; Elizabeth Hinde
Journal:  Sci Rep       Date:  2021-05-26       Impact factor: 4.379

9.  The Switch from NF-YAl to NF-YAs Isoform Impairs Myotubes Formation.

Authors:  Debora Libetti; Andrea Bernardini; Sarah Sertic; Graziella Messina; Diletta Dolfini; Roberto Mantovani
Journal:  Cells       Date:  2020-03-24       Impact factor: 6.600

Review 10.  Transcription Factors in Cancer: When Alternative Splicing Determines Opposite Cell Fates.

Authors:  Silvia Belluti; Giovanna Rigillo; Carol Imbriano
Journal:  Cells       Date:  2020-03-20       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.